Quest Diagnostics Inc (DGX)

[oxnous]

DGX on the list during this selloff

[oxnous]

DGX in Seeking Alpha

https://seekingalpha.com/article/4481363-quest-diagnostics-last-stock-standing-on-my-quality-plus-value-screen?mailingid=26477789&messageid=investing_ideas&serial=26477789.58155&utm_campaign=Stock%2BIdeas%2BRecurring%2B%2B2022-01-25&utm_content=investing_ideas_control&utm_medium=email&utm_source=seeking_alpha&utm_term=Investing%2BIdeas

[whytestocks]

JUST IN: $DGX 3 Back-to-School Stocks to Buy Right Now

School's back in session, and with the coronavirus pandemic still around, it's going to be a challenging year for teachers and students. For investors, however, it's an opportunity to invest strategically in companies that are likely to see demand for their products and services rise as the...

Find out more DGX - 3 Back-to-School Stocks to Buy Right Now

[TFMG]

$DGX | #QuestDiagnostics on Breakout Alert


alert set for break above $125.
Will look for confirmation with volume on 3-5min closes.
Multiple Fib expansion and extension targets provided with $130 & $137
levels as levels of confluence
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

[whytestocks]

News: $DGX FDA Authorizes Quest Diagnostics COVID-19 Diagnostic Testing for Specimen Pooling for Emergency Use

SECAUCUS, N.J. , July 18, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to use specimen pooling ...

Read the whole news DGX - FDA Authorizes Quest Diagnostics COVID-19 Diagnostic Testing for Specimen Pooling for Emergency Use

[BottomBounce]

$DGX https://247wallst.com/healthcare-business/2020/05/11/covid-19-testing-continues-to-lift-aytu-bioscience-stock/

[javanader13]

Quest Diagnostics shares are trading higher after Morgan Stanley maintained an Overweight rating and raised its price target from $139 to $146.

[javanader13]

Ready to break new highs!

[Boss13]

Is quest using the same antibody test that tomdf is using? Both news came out today. Is it arrayit finger stick

[weedtrader420]

DGX$$$$$ $120 TARGET PRICE

[weedtrader420]

tavito DGX$$$$ back over $100 today WOOHOOOOOOOOOOO GOOD LUCK $120 Target price this week

[tavito]

I’m with you!!

[weedtrader420]

DGX$$$$ BUYING any dip here $$$$$

[weedtrader420]

DGX$$$$$ helping to fight against Chinese biological warfare attack. Let's drop a nuclear bomb on them before they kill us they hate us. President should stop Chinese from buying our real estate here. Pretty soon America will be China. They're taking the money they stole from USA and buying our real estate with it. We're fighting to silent Wars against China them buying our real estate and then putting deadly germs here. And don't forget the fish that they are putting in our Waters and the bugs that they were letting lose here that is killing our plants and trees. These motherfckers live off of bugs and the species of fish that they are putting in our Waters they eat. Chinese planned on coming to live here in the United States killing us off. They have no other choice they have too many people in their country they cannot breathe.

[weedtrader420]

DGX$$$$$ Millionaires play WOOHOOOOOOOOOOOO maybe big buy out here

[weedtrader420]

DGX$$$BIG GREEN MOVE COMING WOOHOO$$$ $130 Target price this week

[weedtrader420]

WOOHOOOOOOOO DGX$$$$ $200 TARGET PRICE

[cottonmather]

A friend asked me to do analysis on this stock. I am a technician by trade. I thought I'd put up my two cents...…

Quest is like many of the larger companies right now - most insiders are distributing. The Fed has everything screwed up. Insiders are getting out while there is something to get out of.

Monthly chart was a solid long March of 2019. After seeing insider action I quit researching Quest. That said, the 2008/09 jacking was not severe and the coming jacking may be similar, however, this time will likely be far more severe.

[whytestocks]

News: $DGX Quest Diagnostics Reports First Quarter 2019 Financial Results

SECAUCUS, N.J. , April 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019 . "We're off to a good start in 2019, wi...

Find out more https://marketwirenews.com/news-releases/quest-diagnostics-reports-first-quarter-2019-financial-results-8041322.html

[JoeRoganFan]

I'm sitting in a quest diagnostics right now for the first time. First thing I notice is no secretary to check in, just a computer. I'm thinking this company is making money hand over fist and are cut throut. So I check the stock and see it's down about 20% since October. How come?

[whytestocks]

News: $DGX Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year

SECAUCUS, N.J. , Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive yea...

Find out more https://marketwirenews.com/news-releases/quest-diagnostics-named-one-of-2019-world-s-most-admired-companies-by-fortune-magazine-for-fourth-consecutive-year-7429856.html

[ITMS]

In Quest $DGX Of A Trade Level

This morning, leading diagnostic testing and information services company to the healthcare industry, Quest Diagnostics Inc (NYSE:DGX), is falling sharply after lowering guidance. Quest Diagnostics Inc (NYSE:DGX) stock is dropping by 9.32 percent to $87.87 a share. The stock is breaking down from a bearish daily chart base and this indicates lower prices ahead. The next key support level that should be watched closely will be the $80.00 area. This is where the stock broke out of a monthly chart bullish base in 2017. Often, when stocks retest prior break-out levels it will be defended by the institutional money crowd.





Nicholas Santiago
InTheMoneyStocks

[Grandmasters]

Waiting for another DIP 100<

[Grandmasters]

$111.50 New 52WK High

hats off to QUEST!

[Grandmasters]

She needs to cool down.

Good money made and another divi soon!

[Grandmasters]

10% expecting market pullback EOW

[Grandmasters]

Div Paid

THX

[Grandmasters]

Exec Orders Will be challenged

if he proceeds. 10 Billion dollar company should be trading in the $150.00 range!

[Grandmasters]

In @ 92.58

[Grandmasters]

10% GAINS COMING!

BUY BUY BUY

[ford7319]

Totally agree. Value added IMHO.

[ValueInvestor15]

Cashflow models imply Quest Diagnostics Inc $DGX has 7% Upside before earnings Thursday:

Fair Value Analysis

[Monksdream]

Even though it's trading at an all time high I'm taking a starter position with 10 shares with the idea of dollar averaging.

[Magnum7419]

DGX needs SGBY IMHO

[cadillac107]

If legit. I wonder who it could be that approached them? Unlikely that Laboratory Corp., the nations largest lab testing concern, would be in a position to do so. The timing is certainly not right for them, having just acquired Covance. Besides, doubt if the Govt. would allow them to become such a dominant force in the industry.

[Wildbilly]

yup, lol, may as well make it a whopper

[KingDMC]

Hell of a premium if legit!!

[Wildbilly]

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113954425

[9HikeDiscGolf]

CRAZY SPIKE.. INSANE!

[KingDMC]

Nothing yet watching closely

[higger1298]

Are you hearing anything about who might be buying them out?

[KingDMC]

DGX halted

[Mygolfballs]

LPDX 5M in float with 54M revenues short interest changed and 2014 going to be a leader alongside ALR DGX watch n learn

12/13/2013 29,097 81,862 1.000000
11/29/2013 60,777 134,670 1.000000
11/15/2013 63,887 64,714 1.000000
10/31/2013 75,875 29,420 2.579028
10/15/2013 89,643 18,437 4.862125
9/30/2013 94,361 29,945 3.151144
9/13/2013 126,033 27,355 4.607311
8/30/2013 136,853 26,915 5.084637


Read more: www.nasdaq.com/symbol/lpdx/short-interest#ixzz2pjDBoGwE

[Penny Roger$]

59.90 +0.82 (1.39%)
Jun 29 - Close
NYSE real-time data - Disclaimer
Currency in USD Range 59.35 - 60.19
52 week 45.12 - 62.32
Open 59.81
Vol / Avg. 1.61M/1.21M
Mkt cap 9.50B
P/E 14.01
Div/yield 0.17/1.14
EPS 4.28
Shares 158.65M
Beta 0.61
Inst. own 93%

[Penny Roger$]

~ Wednesday! $DGX ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $DGX ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=DGX&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=DGX&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=DGX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=DGX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=DGX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=DGX
Finviz: http://finviz.com/quote.ashx?t=DGX
~ BusyStock: http://busystock.com/i.php?s=DGX&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=DGX >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

[Penny Roger$]

Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. On April 4, 2011, the Company acquired Athena Diagnostics (Athena). On May 17, 2011, the Company acquired Celera Corporation (Celera). In January 2012, the Company acquired S.E.D. Medical Laboratories.

http://www.google.com/finance?q=DGX